Home

Sergio Traversa, CEO: Relmada Therapeutics RLMD Buy · Filed 24/01/31

Trade details

Type
Insider buy
Amount
$117,017.11
Shares · price
31,541 sh · $3.71 a share
Held after
175,565 sh
Trade date
24/01/29
Filed
24/01/31
Days to filing
2 days

First buy since 2023

Insiders buying this week
3 insiders
Holding change
+21.9%

Relmada Therapeutics trades, last 26 weeks

What else happened in Relmada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/30~24/02/28

Sergio Traversa's recent trades

  • Sergio Traversa

    BuyRelmada Therapeutics

    $113.3K

    Filed 25/12/16

  • Sergio Traversa

    BuyRelmada Therapeutics

    $599.5K

    Filed 25/11/06

  • Sergio Traversa

    BuyRelmada Therapeutics

    $86.7K

    Filed 25/08/28

  • Sergio Traversa

    BuyRelmada Therapeutics

    $49.9K

    Filed 25/08/28

  • Sergio Traversa

    BuyRelmada Therapeutics

    $41.4K

    Filed 25/08/28